Evidence map›Paper›PMID 26405298›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Cystathionine β-synthase regulates endothelial function via protein S-sulfhydration.

Sounik Saha, Prabir K Chakraborty, Xunhao Xiong, Shailendra Kumar Dhar Dwivedi, Soumyajit Banerjee Mustafi, Noah R Leigh, Ramani Ramchandran, Priyabrata Mukherjee, Resham Bhattacharya

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. HBiochemistry · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Cystathionine-The Journal of international medical research · 2024
    Article
  15. Chemoselective Proteomics, Zinc Fingers, and a Zinc(II) Model for HAngewandte Chemie (International ed. in English) · 2024
    Article
  16. Article
  17. VEGF signaling: Role in angiogenesis and beyond.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  18. Article
  19. Review
  20. Role of post-translational modifications of Sp1 in cardiovascular diseases.Frontiers in cell and developmental biology · 2024
    Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sounik Saha*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Prabir K Chakraborty*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Xunhao Xiong*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Shailendra Kumar Dhar Dwivedi*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Soumyajit Banerjee Mustafi*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Noah R Leigh*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Ramani Ramchandran*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Priyabrata Mukherjee*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA priyabrata-mukherjee@ouhsc.edu resham-bhattacharya@ouhsc.edu.
Resham Bhattacharya*Peggy and Charles Stephenson Cancer Center, Department of Obstetrics and Gynecology, Department of Pathology, and Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA; and Developmental Vascular Biology Program and Zebrafish Drug Screening Core, Department of Obstetrics and Gynecology, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA priyabrata-mukherjee@ouhsc.edu resham-bhattacharya@ouhsc.edu.
University of Oklahoma Health Sciences Center · USMedical College of Wisconsin · US

Funding

Cystathionine beta synthase (CBS) and angiogenesisR01HL120585 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BHATTACHARYA, RESHAM, MUKHERJEE, PRIYABRATA · 2013 to 2017
$2.1M
NHLBI NIH HHS R01 HL120585NHLBI NIH HHS R01HL120585
6 · The paper itself

Abstract

Deficiencies of the human cystathionine β-synthase (CBS) enzyme are characterized by a plethora of vascular disorders and hyperhomocysteinemia. However, several clinical trials demonstrated that despite reduction in homocysteine levels, disease outcome remained unaffected, thus the mechanism of endothelial dysfunction is poorly defined. Here, we show that the loss of CBS function in endothelial cells (ECs) leads to a significant down-regulation of cellular hydrogen sulfide (H2S) by 50% and of glutathione (GSH) by 40%. Silencing CBS in ECs compromised phenotypic and signaling responses to the VEGF that were potentiated by decreased transcription of VEGF receptor (VEGFR)-2 and neuropilin (NRP)-1, the primary receptors regulating endothelial function. Transcriptional down-regulation of VEGFR-2 and NRP-1 was mediated by a lack in stability of the transcription factor specificity protein 1 (Sp1), which is a sulfhydration target of H2S at residues Cys68 and Cys755. Reinstating H2S but not GSH in CBS-silenced ECs restored Sp1 levels and its binding to the VEGFR-2 promoter and VEGFR-2, NRP-1 expression, VEGF-dependent proliferation, and migration phenotypes. Thus, our study emphasizes the importance of CBS-mediated protein S-sulfhydration in maintaining vascular health and function.-Saha, S., Chakraborty, P. K., Xiong, X., Dwivedi, S. K. D., Mustafi, S. B., Leigh, N. R., Ramchandran, R., Mukherjee, P., Bhattacharya, R. Cystathionine β-synthase regulates endothelial function via protein S-sulfhydration.

Indexed as

Cell MovementCell ProliferationCystathionine beta-SynthaseEndothelium, VascularGlutathioneHumansHuman Umbilical Vein Endothelial CellsHydrogen SulfideNeuropilinsSecond Messenger SystemsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Cystathionine beta-SynthaseGlutathioneHydrogen SulfideKDR protein, humanNeuropilinsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2angiogenesismetabolismsignal transductionVEGFRs

Identifiers

PMID26405298
PMCPMC4684530
OpenAlexW2222562619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.